To test this hypothesis, we first targeted KDM4C genetically or pharmacologically in multiple human lung cancer cell lines and Lewis cells and detected a significant increase in the protein expression of CXCL10 (figure 3G, H and online supplemental figure S5A). Here, KDM4C is linked to lung carcinoma.